Cytrx is not sitting on their hands doing nothing for the next 12 months implying zero spending on development. They have most of their people over in Germany and will start development of DK 049. A company do not sit idle waiting for Aldox approval. They have to keep advancing their pipeline. Expense will go up, you can bet on that. Question is how they manage their resources and whether or not they need more funding prior to Aldox milestone payment. We have nothing from management of a forward guidance and whether or not they will have enough cash to last until Aldox approval.
On separate news, seems like Altor Bo is going through and investors will have to settle after the deal.
News 
Market Data 
Discover 
